Fragment 176-191 Research Overview
Ultima-HGH Fragment 176-191 is a synthetic peptide consisting of amino acids 176-191 from the C-terminal region of human growth hormone. This fragment represents the specific sequence responsible for lipolytic activity without affecting glucose metabolism or insulin sensitivity in preclinical models. Researchers at Stroid UK Shop examine this peptide for its selective metabolic properties and tissue-specific effects in laboratory settings.
Laboratory Research Applications
Scientists investigate Fragment 176-191 for its unique mechanism of action in adipose tissue research. Unlike full-length growth hormone, this fragment demonstrates selective lipolytic activity without impacting carbohydrate metabolism pathways. Research models show the peptide binds to specific receptor sites and activates adenylyl cyclase, leading to increased cAMP levels in fat cells. Studies within our Fragment 176-191 peptide collection focus on metabolic pathway analysis and cellular energy expenditure mechanisms. Comparative research with other metabolic modulators from our SARMs catalogue provides insights into selective tissue targeting approaches.
Product Specifications
| Parameter | Specification |
|---|---|
| Chemical Name | HGH Fragment 176-191 |
| Sequence | Tyr-Leu-Arg-Ile-Val-Gln-Cys-Arg-Ser-Val-Glu-Gly-Ser-Cys-Gly-Phe |
| Molecular Weight | 1815.08 g/mol |
| Purity | ≥98% by HPLC |
| Vial Content | 5mg lyophilised powder |
| Storage Conditions | -20°C lyophilised, 2-8°C reconstituted |
| Manufacturer | Ultima Pharmaceuticals |
Research protocols typically examine this fragment’s effects on lipolytic enzyme activation and beta-3 adrenergic receptor pathways. Laboratory studies within our broader peptides research portfolio investigate dose-response relationships and temporal activity patterns in cellular models. Scientists evaluate the peptide’s stability under various experimental conditions and its interaction with other metabolic signalling molecules.
Research Compliance Statement
Ultima-HGH Fragment 176-191 is manufactured exclusively for in-vitro laboratory research purposes. This product is not intended for human consumption, therapeutic use, or any application outside controlled scientific environments. Researchers must ensure compliance with institutional protocols and local regulations when conducting studies with this material. All experimental work should be performed under appropriate laboratory safety conditions with qualified scientific supervision.
